Objective: To investigate the impact of peroxisome proliferator-activated receptor a deficiency on gene expression of adipose triglyceride lipase and the glycerol transporter aquaglyceroporin 7 in white adipose tissue in the fed and fasted states in relation to glycerol release by isolated adipocytes. Measurements: Studies using wild-type and peroxisome proliferator-activated receptor a null mice. Hormone and metabolite concentrations, real-time polymerase chain reaction (PCR), basal and stimulated adipocyte lipolysis, estimated by glycerol release. Results: Peroxisome proliferator-activated receptor a deficiency blocked the increase in aquaglyceroporin 7 transcript level and attenuated the increase in adipose triglyceride lipase transcript level in white adipose tissue elicited by fasting. Fasting glycerol levels were lower in peroxisome proliferator-activated receptor a null than wild-type mice, despite increased mobilization of adipocyte fat reserves in vivo as indicated by reduced adipose tissue masses (three distinct depots) and a significantly lower epididymal adipocyte diameter. Basal net glycerol release was unchanged but b-adrenergic-stimulated net glycerol release was higher with isolated adipocytes from fasted peroxisome proliferator-activated receptor a null mice compared with those of fasted wild-type mice. Conclusion: Peroxisome proliferator-activated receptor a deficiency prevents effects of fasting to increase adipocyte aquaglyceroporin 7 gene expression, and influences the regulation of inter-tissue glycerol flux after fasting via lowered adipocyte aquaglyceroporin 7 expression. Lowered gene expression of adipose triglyceride lipase and aquaglyceroporin 7 in peroxisome proliferator-activated receptor a null mice is not limiting for adipose triglyceride breakdown in vivo during fasting.
Introduction
The ability of adipocytes to store fatty acids (FA) as triglyceride (TAG) provides a fuel store; sequestration of excess dietary FA in adipose tissue can improve insulin action in liver and muscle by suppressing excess FA delivery to these tissues (reviewed in Reference Frayn 1 ). In response to lipolytic stimulation, adipocytes hydrolyse stored TAG, releasing non-esterified FA (NEFA) and glycerol for use as oxidative substrates for adenosine triphosphate (ATP) production and hepatic gluconeogenesis, respectively. Until recently, hormone-sensitive lipase (HSL) was considered responsible for lipolytic degradation of adipocyte TAG stores. However, HSL-deficient mice, which do not store excessive TAG within adipocytes, exhibit decreased adipose tissue mass and an altered adipose lipid composition with marked diacylglycerol (DAG) accumulation, suggested a second regulatory lipase. [2] [3] [4] In addition, although b-agonist-induced lipolysis is lower in HSL null mice, adipocyte stored TAG can be mobilized and basal lipolysis is normal. 4, 5 This led to the discovery of a neutral TAG lipase activity, adipose triglyceride lipase (ATGL) (patatin-like phospholipase domain-containing protein 2, desnutrin, calcium-independent phospholipase A2z (iPL-A2z), adiposome triglyceride lipase), which is predominantly expressed in adipose tissue and whose expression is enhanced by fasting. 6 Inactivation of the ATGL gene in mice drastically reduces b-adrenergic (isoproterenol (ISO))-stimulated lipolysis in explants of gonadal white fat, whereas basal lipolysis is unchanged. 7 It was suggested that HSL is unable to compensate for the absence of ATGL in white adipose tissue under conditions of stimulated lipolysis and that, in mice, ATGL is rate-limiting for initiation of TAG catabolism. ATGL deficiency in mice is associated with increased glucose tolerance and insulin sensitivity after fasting. 7 Aquaglyceroporin (AQP) 7 (AQPap/7 in man) is highly expressed in adipose tissue, 8 where it functions as a major glycerol channel. AQP7 mRNA expression is enhanced by fasting, 9 a condition favouring increased glycerol production from stored TAG. AQP7 knockout mice show an impaired increase in plasma glycerol in response to b3-adrenergic agonist stimulation in vivo 10 and AQP7 knockdown in 3T3-L1 adipocytes by siRNA suppresses b-adrenergic-stimulated glycerol release by 50%. 10 Glycerol retention within adipose tissue secondary to AQP7 deficiency appears to initiate metabolic perturbations that promote expansion of the adipose tissue mass under anabolic conditions. AQP7 knockout mice develop obesity with age or when placed on a highfat diet, 11, 12 with a 2-fold increase in adipocyte TAG content at 16 weeks.
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The phenotype of PPARa null mice resembles that of ATGL null mice (increased glucose tolerance and insulin sensitivity after fasting). 7, 13 PPARa also modulates hepatic glycerol metabolism. 14 Several hepatic genes involved in glycerol metabolism, including glycerol transporters AQP3 and 9, are upregulated by fasting in wild-type mice but not in mice lacking PPARa. 14 We therefore hypothesized that, although PPARa is not highly expressed in white adipose tissue, PPARa deficiency might impact white adipose tissue metabolism, possibly to compensate for fasting-induced metabolic disruptions in FA and glycerol handling. In addition, since phenotypes of PPARa null mice and of ATGL and AQP7 knockout mice exhibit striking similarities, we investigated the impact of PPARa deficiency on ATGL and AQP7 mRNA expression in white adipose tissue of fed and 16 h-fasted wild type and PPARa null mice in relation to lipolysis and glycerol release by isolated adipocytes. 
Materials and methods

Animals
Serum analyses
Insulin was analysed by ELISA (Mercodia, Uppsala, Sweden) and glucose by a glucose oxidase/peroxidase method (Roche Diagnostics, Lewes, UK). NEFA and glycerol were determined using commercial kits purchased from Alpha Labs (Eastleigh, UK) and Sigma (Poole, Dorset, UK), respectively.
AQP7 and ATGL mRNA expression in epididymal adipose tissue Total RNA, was extracted using Tri-reagent (Sigma, Poole, UK), quantified, diluted to 0.5 mg/ml and treated with RNasefree DNase (Promega, Southampton, UK). Complimentary DNA (cDNA) was prepared using the Superscript II Preamplification System (Invitrogen, Paisley, Scotland). Realtime PCR was performed using Taqman pre-designed gene expression assays for AQP7, ATGL and TATA box-binding protein (TBP) as endogenous control (Applied Biosystems, CA, USA) in a Rotorgene 2000 system (Corbett, Cambridge, UK). Results were analysed with accompanying software and gene expression normalized to that of TBP.
In vivo responses to insulin A fasting sample was taken from the tail vein before i.p. injection of the leucine derivative keto-isocaproate (KIC; 1 g/kg body weight). Plasma was collected at 5 and 20 min post-KIC injection. Epididymal adipose tissue (EPI) was obtained from 16 h-fasted mice at 60 min after KIC administration.
Adipocyte incubation
Epididymal fat pads were collected in Krebs-Ringer HEPES buffer (KRHB) containing 3% insulin-free bovine serum albumin (BSA), 200 nM adenosine and 5 mM glucose (KRHB, pH 7.4) and adipocytes isolated as described previously. 15 Adipocyte numbers were determined by counting under phase-contrast microscopy. Adipocyte size was determined PPARa and adipocyte gene expression CG Walker et al using the programme Image J by microscopic measurement of 100-120 cells per preparation using seven preparations.
Adipocyte lipolysis
The rate of lipolysis was determined by glycerol release into the media from adipocytes incubated at 371C for 4 h. 16 Isolated adipocytes were incubated with 3 mM glucose, 20 mM glucose þ 0.1 mM ISO and 20 mM glucose þ 0.1 mM ISO þ 1.6 nM insulin.
Statistical analyses
Results are presented as the mean7s.e.m. Statistical analyses were performed by analysis of variance (ANOVA) followed by Fisher's post-hoc tests for individual comparisons or unpaired (in vivo) or paired (in vitro) Student's t-tests as appropriate.
Results
Serum analysis of fed and fasted wild-type and PPARa null mice Serum glucose, insulin and NEFA concentrations were unaffected by PPARa deficiency in the fed state ( Figure 1a c), whereas serum glycerol concentrations were moderately elevated in fed PPARa null mice compared to fed wild-type mice ( Figure 1d ). Glycemia in the PPARa null mice was lower (by 25%; Po0.001) than that of wild-type mice in the 16 hfasted state (Figure 1a ), whereas there was a trend towards higher serum insulin levels (although this did not quite achieve statistical significance (Figure 1b) ). Serum NEFA concentrations were higher in PPARa null mice than in wild type in the fasted state ( Figure 1c ) (see also References Sugden et al. 17 and Kersten et al.
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), whereas serum glycerol concentrations were significantly lower (by 49%; Po0.001) in the PPARa knockout mice than in the wild-type mice in the fasted state ( Figure 1d ).
ATGL mRNA expression in EPI in fed and fasted wild-type and PPARa null mice ATGL mRNA was expressed at similar levels in EPI from fed wild-type mice and fed PPARa null mice (Figure 2a) . At 16 h after food withdrawal, ATGL mRNA expression in EPI of wild-type mice was increased by 3.6-fold (Po0.001) compared with the ad libitum-fed state (Figure 2a ). Fasting also increased ATGL mRNA expression in EPI from PPARa null mice, but to a lesser extent (2.5-fold; Po0.05) than in wild-type mice such that levels of expression were significantly lower (38%; Po0.05) than in EPI from fasted wild-type mice (Figure 2a ).
AQP7 mRNA expression in EPI in fed and fasted wild-type and PPARa null mice AQP7 mRNA was expressed at similar levels in adipose tissue from fed wild-type mice and fed PPARa null mice (Figure 2b ).
However, fasting revealed a striking effect of PPARa deficiency to preclude fasting-induced increases in AQP7 expression. At 16 h after food withdrawal, AQP7 mRNA expression in adipose tissue of wild-type mice was significantly increased 2.7-fold (Po0.001) compared with the ad libitum-fed state, whereas AQP7 mRNA expression in adipose tissue from PPARa null mice was unchanged, and was significantly lower (81%; Po0.001) than that observed in adipose tissue from fasted wild-type mice.
ATGL and AQP7 mRNA expression in EPI of fasted mice are rapidly downregulated by a rise in insulin in vivo To differentiate between nutrient-led (re-feeding) and insulin-led alterations in mRNA expression in the regulation of ATGL and AQP7 mRNA expression in vivo, we administered the insulin secretagogue keto-isocaproic acid (KIC), which generates a rise in insulin in the absence of altered glycemia to 16 h-fasted mice. Plasma insulin increased at 5 min after i.p. administration of KIC in mice of both genotypes to (Figure 2a, designated insulin (INS) ). Similarly, the fasting-induced increase in AQP7 expression observed in wild-type mice was rapidly reversed by acute exposure to insulin in vivo (Figure 2b ).
Lipolysis with adipocytes from fed wild type and PPARa null mice Basal rates of glycerol release did not differ between adipocytes from fed wild-type or fed PPARa null mice (Figure 3a ). On stimulation with ISO, lipolysis increased 4.9-fold (Po0.01) with adipocytes from fed wild-type mice, but 6.1-fold (Po0.05) with adipocytes from fed PPARa null mice (compare Figure 3a and b) . Inclusion of insulin (1.6 nM) in addition to ISO in the medium suppressed ISO-stimulated lipolysis by 57% to 2.1-fold of basal with adipocytes from fed wild-type mice and by 64% to 2.2-fold of basal with adipocytes from fed PPARa null mice (compare Figures 3b  and c) .
Effects of fasting on lipolysis with adipocytes from wild type and PPARa null mice Basal glycerol release was unaffected by starvation with adipocytes from either genotype (Figure 3a) . ISO-stimulated lipolysis was moderately potentiated by fasting (a 6.5-fold increased in glycerol release with adipocytes from fasted wild-type mice, compared with the 4.9-fold increase observed with adipocytes from fed wild-type mice) (Figure 3b (Figure 3b) . Thus, glycerol release in the absence of insulin is 2.6-fold higher (Po0.05) with adipocytes from fasted PPARa null mice than with adipocytes from fed wildtype mice. With adipocytes from fasted wild-type mice, inclusion of insulin (1.6 nM) in addition to ISO suppressed ISO-stimulated lipolysis by 58% to 2.7-fold of basal, whereas with adipocytes from PPARa null mice, insulin suppressed ISO-stimulated lipolysis by 56%, to 5.0-fold of basal.
Adipocyte size and adipose depot weights after fasting Epididymal adipocyte diameter was significantly lower (by 15%; Po0.001) when prepared from 16 h-fasted PPARa null mice compared with wild-type mice (Figure 4a ). In view of apparently augmented lipolysis, we also measured adipose tissue mass from three distinct depots, perirenal (PR) and subcutaneous (SC) adipose tissue, as well as EPI in 16 h-fasted PPARa null mice and 16 h-fasted wild-type mice. Both absolute fat pad weights (not shown) and fat pad weights relative to body weight ( Figure 4b ) were significantly lower in fasted PPARa null mice. In contrast, liver weight was increased in fasted PPARa null mice compared with the fasted wild-type mice (Figure 4c ).
Discussion
The present study demonstrates that PPARa deficiency completely blocks the increase in adipose tissue AQP7 transcript level and attenuates the increase in adipose tissue ATGL transcript level that occurs in response to fasting. Consistent with decreased adipocyte AQP7 expression, systemic glycerol levels after fasting were lower in 16 hfasted PPARa null mice than 16 h-fasted wild-type mice. However, rates of b-adrenergic stimulated lipolysis (assessed from net glycerol release) were higher with adipocytes from fasted PPARa null mice than with adipocytes from fasted wild-type mice. Mobilization of adipocyte fat reserves in vivo is indicated by reduced mass of individual adipose tissue depots from fasted PPARa null mice and lower epididymal adipocyte size in fasted PPARa null mice compared with fasted wild-type mice. Thus, there is no in vivo evidence suggesting that lowered gene expression of either ATGL or AQP7 in fasted PPARa null mice is limiting for TAG breakdown, although lowered AQP7 expression may impact glycerol release. Enhanced expression of ATGL after fasting in wild-type mice has been suggested to be mediated by glucocorticicoids. 6 Our finding of lowered ATGL gene expression in adipose tissue of PPARa null mice after fasting is therefore of interest. White adipocytes are not generally regarded as PPARa target cells; however, PPARa gene expression has recently been detected in mouse EPI. 19 It has been suggested that PPARa is essential for maintenance of normal adiposity in that, in its absence, endogenous cholesterol promotes TAG loss from adipose tissue. 19 In liver, PPARa expression is increased by physiological stress, a response prevented by the anti-glucocorticoid RU486 20 and glucocorticoids induce PPARa expression in cultured hepatocytes and intact liver in rodents. 20 There is a key involvement of PPARa and, by implication, hepatic FA oxidation in allowing the induction of hepatic insulin resistance in response to dexamethasone. 20 PPARa and adipocyte gene expression CG Walker et al during fasting may also require functional PPARa signalling, either directly or, perhaps, through promoting extra-adipocyte clearance of FA to signal a requirement for enhanced lipolysis. AQP7 is a direct PPARg target gene in adipocytes, 9, 21 responding to PPARg agonists (the thiazolidinediones) in culture with increased adipocyte AQP7 mRNA expression.
14 AQP7 mRNA expression in adipose tissue is enhanced by fasting, 9 a condition favouring lipolysis and, therefore, increased FA and glycerol production from stored TAG. The mechanisms by which AQP7 mRNA expression in adipose tissue is enhanced during fasting are incompletely elucidated, but would not be expected to involve increased signalling through PPARg, which is perceived as a transcription factor promoting TAG synthesis/storage associated with feeding rather than fasting. Lipolytic hormones (adrenaline, glucagon, ACTH) do not change AQP7 mRNA expression; 8 however, it is enhanced by insulin deficiency induced by streptozotocin and suppressed by the elevation in insulin elicited by refeeding. 9 Furthermore, AQP7 mRNA expression in mesenteric adipose tissue is increased in insulin-resistant, but hyperinsulinemic, db/db mice. 22 A direct inhibitory effect of insulin on AQP7 gene expression is implied by the identification of a negative insulin response element in the mouse 22 and human 23 AQP7
gene promoter. Thus, removal of the restraint on lipolysis imposed by insulin appears coupled with increased adipocyte AQP7 expression. Conversely, elevation of insulin in vivo, in the absence of increased glycemia, rapidly (within 30 min) reversed effects of fasting to enhance AQP7 expression in EPI of wild-type mice (present study). PPARa signalling is important for lipid homeostasis during fasting, where it enhances expression of genes involved in FA oxidation in liver and skeletal muscle to facilitate ATP generation from FA. We demonstrate that fasting-induced increases in AQP7 mRNA expression in adipose tissue are completely prevented in PPARa null mice. Circulating insulin levels tended to decline on fasting in PPARa null mice, although this effect did not achieve statistical significance, suggesting that the effect of PPARa deficiency was not attributable to relatively high insulin levels.
The contribution of glycerol to glucose production may vary from 5% postprandially in humans, 24 to 50% in the postabsorptive state in rodents 25 and 490% in rodents after prolonged fasting. 25 The significance of glycerol as a gluconeogenic precursor in man is supported by episodic hypoglycaemia observed in patients with glycerol kinase deficiency. 26 AQP7 knockout mice show lower hepatic portal glycerol concentrations after fasting and severe fasting hypoglycaemia, despite unimpaired hepatic gluconeogenesis from administered glycerol. 10 Thus, AQP7 is required for efficient release of glycerol from adipose tissue during fasting. Glycerol levels are low when its rate of removal exceeds its generation; systemic glycerol levels after fasting were lower in 16 h-fasted PPARa null mice than 16 h-fasted wild-type mice. It has been suggested that hepatic glycerol utilization for gluconeogenesis is lower in fasted PPARa null mice than in fasted wild-type mice, 14 which would be predicted to result in higher circulating glycerol levels. Our data are therefore consistent with lower glycerol release from adipose tissue in vivo in fasted PPARa null mice. This finding would be consistent with lowered adipocyte AQP7 gene expression, but not necessarily with apparently accelerated lipolysis observed in vitro with PPARa-deficient adipocytes.
As lipolytic rates were calculated from rates of net glycerol release, we cannot exclude the possibility that under the conditions of in vitro adipocyte incubation (4 h), there is glycerol movement both out of and into the adipocyte. Previous studies show that glycerol uptake into isolated adipocytes is 3-fold reduced in adipocytes from AQP7-deficient mice. 11 Thus, lowered AQP7 expression in adipocytes from PPARa null mice is predicted to limit glycerol reentry under in vitro conditions (where glycerol accumulates in the medium) resulting in an overestimation of the rate of lipolysis. Nevertheless, lowered glycerol concentrations in vivo likely reflect the lower AQP7 expression in adipose tissue of PPARa null mice. As adipose depot weights were less in fasted PPARa null mice than fasted wild-type mice, lower circulating glycerol concentrations observed in fasted PPARa null mice may also reflect the reduced adipose tissue mass, in addition to the possible limit set on glycerol release through lower AQP7 expression. Our findings support the hypothesis of coordinated regulation of adipose tissue AQP7 and hepatic AQP9. 22 Fasting and refeeding of mice increased and decreased hepatic AQP9 mRNA expression, respectively, reiterating the pattern for AQP7 mRNA expression in adipose tissue. Similarly, gene expression of AQP9 in liver and AQP7 in adipose tissue are both increased in insulin-resistant db/db mice. 22 Hepatic AQP9 is upregulated by fasting in wild-type mice, but not in PPARa null mice. 14 Our study now demonstrates that adipocyte AQP7 is upregulated by fasting in wild-type mice, but not in mice lacking PPARa. Our study therefore implicates PPARa as a transcription factor that is involved in the coordinate regulation of inter-tissue glycerol flux, and it is suggested that coordinated loss of AQP7 and AQP9 contribute to the development of fasting hypoglycaemia in situations of deficient PPARa signalling, whereas coordinate dysregulation of AQP7 and AQP9 by insulin could contribute to chronic hyperglycaemia observed in insulin resistance.
